Edesa Biotech, Inc. (EDSA)
Automate Your Wheel Strategy on EDSA
With Tiblio's Option Bot, you can configure your own wheel strategy including EDSA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol EDSA
- Rev/Share 0.0
- Book/Share 2.9288
- PB 0.6948
- Debt/Equity 0.0
- CurrentRatio 15.729
- ROIC -0.4167
- MktCap 14291154.0
- FreeCF/Share -1.0788
- PFCF -2.4967
- PE -1.8495
- Debt/Assets 0.0
- DivYield 0
- ROE -1.0309
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced that it has sold, in a private placement, an aggregate of 834 newly designated Series B-1 convertible preferred shares (“Series B-1 Preferred Shares”) and 3,468,746 common shares in a private placement priced at-the-market under the rules of the Nasdaq Stock Market. The purchase price per Preferred Share was $10,000 and the purchase price per common share was $1.92. Officers and directors of the Company purchased approximately $1.1 million of the …
Read More
About Edesa Biotech, Inc. (EDSA)
- IPO Date 2010-06-21
- Website https://www.edesabiotech.com
- Industry Biotechnology
- CEO Dr. Pardeep Nijhawan FRCPC, M.D.
- Employees 16